People: Abbott Laboratories (ABT)

ABT on New York Consolidated

53.35USD
9 Feb 2010
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$53.35
Open
--
Day's High
$53.98
Day's Low
$53.34
Volume
11,140,560
Avg. Vol
8,989,495
52-wk High
$57.25
52-wk Low
$41.27

view people for:

Summary

Name Age Since Current Position
White, Miles 54 1999 Chairman of the Board, Chief Executive Officer
Freyman, Thomas 54 2004 Chief Financial Officer, Executive Vice President - Finance
Tyree, James 55 2009 President of Abbott Biotech Ventures Inc
Schumacher, Laura 45 2007 Executive Vice President, General Counsel, Secretary
Ashley, Richard 65 2004 Executive Vice President - Corporate Development
Liepmann, Holger 57 2008 Executive Vice President - Nutritional Products
Bohuon, Olivier 50 2009 Executive Vice President - Pharmaceutical Products
Michael, Edward 52 2008 Executive Vice President - Diagnostic Products
Capek, John 47 2007 Executive Vice President - Medical Devices
Fussell, Stephen 51 2005 Senior Vice President - Human Resources
Landgraf, John 56 2008 Senior Vice President - Pharmaceuticals, Manufacturing and Supply
Chen, Thomas 59 2008 Senior Vice President - International Nutrition
Hance, Robert 49 2008 Senior Vice President - Vascular
Mason, Heather 48 2008 Senior Vice President - Diabetes Care
Patton, Donald 56 2007 Senior Vice President - U.S. Nutrition
Szela, Mary 45 2008 Senior Vice President - U.S. Pharmaceuticals
Warmuth, Michael 46 2008 Senior Vice President - Diagnostics
Mazzo, James 51 2009 Senior Vice President
Linder, Greg 52 2003 Vice President, Controller
Fuller, H. Laurance 71 1988 Director
Owen, David 71 1996 Director
Reynolds, W. Ann 71 1980 Director
Roberts, Roy 70 1998 Director
Smithburg, William 70 1982 Director
Austin, Roxanne 48 2000 Director
Daley, William 60 2004 Director
Farrell, W. James 67 2006 Director
Osborn, William 61 2008 Director
Scott, Samuel 65 2007 Director
Tilton, Glenn 61 2007 Director
Alpern, Robert 58 2008 Director
» Insider Trading

Biographies

Name Description
White, Miles Miles D. White has served as Chairman of the board and Chief Executive Officer of Abbott Laboratories since 1999. He served as an executive vice president of Abbott from 1998 to 1999, as senior vice president, diagnostics operations from 1994 to 1998, and as vice president, diagnostics systems operations from 1993 to 1994. Mr. White joined Abbott in 1984. He received both his bachelor's degree in mechanical engineering and M.B.A. degree from Stanford University. He serves on the board of trustees of The Culver Educational Foundation, The Field Museum in Chicago, and Northwestern University. He serves as a director of Motorola Inc.
Freyman, Thomas Thomas C. Freyman is Executive Vice President, Finance and Chief Financial Officer of Abbott Laboratories. He was appointed to his current role in February 2004 and has served as Abbott's Chief Financial Officer since 2001. Mr. Freyman joined Abbott in 1979, and has served in a number of financial planning and analysis positions. In 1984, Mr. Freyman was appointed Finance Director for Abbott's European distribution center in the Netherlands. He also served as Division Controller, Corporate Materials Management, Vice President and Treasurer, and Vice President and Controller, Hospital Products Division. Prior to joining Abbott, Mr. Freyman was a Certified Public Accountant with Ernst & Whinney, Chicago. Mr. Freyman serves on the board of directors for the Chicago Botanic Garden. He is also a member of the Economic Club of Chicago, the Executives' Club of Chicago, the Healthcare Leadership Council and the S&P Corporate Ratings Issuer Council. He earned a Bachelor's degree in Accounting from the University of Illinois and a Master's degree in Management from Northwestern University.
Tyree, James James L. Tyree was appointed as President of Abbott Biotech Ventures Inc Effective August 1, 2009. He serves as Executive Vice President, Pharmaceutical Products of Abbott Laboratories since 2008. He was appointed to the position of Executive Vice President, Pharmaceutical Products Group in 2007. Mr. Tyree first joined Abbott from 1978 until 1979 as a Business Analyst for a year. He rejoined the company in June 1997 and has been in various management positions including Divisional Vice President and General Manager for Abbott's international division in Japan. He recently served as Vice President, Global Licensing/New Business Development in the Pharmaceutical Products Division and as Senior Vice President, Pharmaceutical Operations. Prior to re-joining Abbott in 1997, Mr. Tyree was President of Sugen Inc., a biotechnology start-up company and held various leadership positions at other pharmaceutical companies. He serves on the board of directors for TAP Pharmaceuticals, a joint venture between Abbott and Takeda Pharmaceutical Company Limited. He is a member of the advisory boards of the Polsky Center of Entrepreneurship at the University of Chicago and the Kellogg Center for Biotechnology at Northwestern University. He is a member of Richard M. Daley's Chicago Mayor's Council of Technology Advisors. Formerly Chairman, he is also Chairman of the board of directors of the Illinois Biotechnology Industry Organization. He earned Bachelor's degrees in Psychology and Forensic Studies and a Master's degree in Business Administration from Indiana University.
Schumacher, Laura Laura J. Schumacher serves as Executive Vice President, General Counsel, Secretary of Abbott Laboratories since 2007. She was appointed to her current role in February 2007. Previously, she served as Senior Vice President, Secretary and General Counsel. Ms. Schumacher joined Abbott in 1990 as a litigation attorney. She has held various positions within the litigation department, including Divisional Vice President, litigation and Vice President, Secretary and Deputy General Counsel. Prior to joining Abbott, Ms. Schumacher was an associate attorney with the law firm Schiff, Hardin & Waite in Chicago. Ms. Schumacher is on the board of directors for the Clara Abbott Foundation, and a member of the Economic Club of Chicago, Chicago Network and Chicago Club. She graduated with a Bachelor's degree in Business Administration/Marketing from the University of Notre Dame and with a Juris Doctorate from the University of Wisconsin at Madison.
Ashley, Richard Mr. Richard W. Ashley is Executive Vice President - Corporate Development of Abbott Laboratories. His responsibilities include various aspects of corporate strategic planning and business development. Ashley was appointed to his current position in February of 2004. Prior to joining Abbott, he was a Senior Director at McKinsey and Company, a former Managing Partner of the firm's Chicago office, and Head of the firm's Global Leadership and Organization practice. During his 31 years with McKinsey, Ashley consulted with clients in healthcare, energy and industrial manufacturing industries across a wide range of business and organizational issues. Mr. Ashley is a member of the Executive Committee of the board of directors of Junior Achievement of Chicago and a former member of the Civic Committee of the Commercial Club of Chicago. He is also a member of the American Bar Association and the Wisconsin Bar Association. He earned a Bachelor's Degree in Political Science and Master's degree in Business Administration from Northwestern University. He also holds a Juris Doctorate from the University of Wisconsin Law School.
Liepmann, Holger Holger A. Liepmann serves as Executive Vice President - Nutritional Products of Abbott Laboratories since 2008. He was appointed to the position of Executive Vice President, Global Nutrition in October of 2006. Previously, he was Executive Vice Ppresident, Pharmaceutical Products Group. Mr. Liepmann also served as Senior Vice President, Abbott International, the commercial operations for Abbott's international pharmaceutical business. Mr. Liepmann first joined Abbott in 1986 as a Business Development Manager for Abbott International, and has since served in various management positions including Divisional Vice President and Regional Director, Europe, and General Manager, Spain, for Abbott's International Division and Vice President, Japan Operations. Prior to joining Abbott, Mr. Liepmann was a Marketing Manager, Europe, for Cutter Laboratories, a subsidiary of Bayer AG. He earned a Bachelor's degree in Psychology from Dartmouth College and a Master's degree in Business Administration from Stanford University.
Bohuon, Olivier Olivier Bohuon was appointed as Executive Vice President - Pharmaceutical Products of Abbott Laboratories effective August 1, 2009. He serves as Senior Vice President, International Pharmaceuticals of Abbott Laboratories since 2008. Mr. Bohuon was Senior Vice President, Abbott International, heading up the company's global pharmaceutical business. He was appointed to this position in April of 2006. Previously he served as Vice President, European Operations, Abbott International. Before rejoining Abbott in 2003, Mr. Bohuon was Senior Vice President of European Commercial Operations at GlaxoSmithKline. Prior to the merger between Glaxo and SmithKline, Bohuon was CEO of SmithKline Beecham France. He also worked at Roussel Uclaf as Marketing and Sales Director, Near and Middle East, and for Boston Consulting Group in Riyadh, Saudi Arabia. Prior to that, Mr. Bohuon was a Marketing Director for Abbott International's anti-infective franchise and later as the Pharmaceutical Products Division Director for Abbott Spain. Mr. Bohuon is a member of the French Academie de Pharmacie and the French Academy of Technologies. He earned a Bachelor's degree in Finance from the Haute Etudes Commerciales (HEC) School of Management in Paris and he received a Doctorate in Pharmacy from the University of Paris XI, France-Sud, Chatenay-Malabry.
Michael, Edward Edward L. Michael serves as Executive Vice President, Diagnostic Products of Abbott Laboratories since 2008. Mr. Michael was Executive Vice President, Diagnostics Abbott's Diagnostics, Molecular and Point-of-care Businesses. He was appointed to this position in July 2007. Previously, he served as Senior Vice President, medical products, Abbott's molecular, spine and animal health business units. Mr. Michael joined Abbott in 1985 as an attorney in the Legal Division. Since 1990, he has held various management positions in Abbott's global diagnostics operations, including Vice President for Europe, Africa and Middle East, and Vice President, Diagnostic Commercial Operations. He also served as Vice President, Immunoassay/Clinical Chemistry, Abbott Diagnostics Division and as Vice President, Abbott Molecular, Abbott's global molecular diagnostic business. He earned a Bachelor's degree in Politics and Government and a Juris Doctorate from Indiana University in Bloomington.
Capek, John John M. Capek is Executive Vice President, Medical Devices of Abbott Laboratories since July 2007. Mr. Capek was appointed to this position in July 2007 and is responsible for Abbott's Vascular, Diabetes Care, Ophthalmology and Animal Health businesses. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Mr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Mr. Capek was manager of New Product Technology at Eli Lilly & Company. Mr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.
Fussell, Stephen Stephen R. Fussell serves as Senior Vice President - Human Resources of Abbott Laboratories since 2005. He was appointed to his current role in April 2005. Previously, he served as Vice President, Compensation and Development. He joined Abbott in 1996, as Divisional Vice President, Compensation and Benefits. Prior to joining Abbott, Mr. Fussell was Vice President, Total Compensation and Workforce Information at Nestlé USA. Mr. Fussell is a board member for the Clara Abbott Foundation and the Abbott Fund. He earned a Bachelor's degree in Management and Administration from Louisiana State University in Baton Rouge.
Landgraf, John John C. Landgraf serves as Senior Vice President, Pharmaceuticals, Manufacturing and Supply of Abbott Laboratories. He served as Senior Vice President, Global Pharmaceutical Manufacturing and Supply from 2004 to 2008. Previously, Mr. Landgraf was Vice President, Quality Assurance and Compliance, for Abbott's Medical Products Group. Mr. Landgraf joined Abbott in 1977 and worked in key positions in plant quality assurance, manufacturing and marketing in Abbott's Diagnostics Division. He also held various management positions in manufacturing and engineering with Abbott International and Abbott Diagnostics Division. Prior to joining Abbott, Mr. Landgraf worked in research and development for Inolex Corporation in Glenwood, Ill. Mr. Landgraf serves on boards for the National Association of Manufacturers, Northern Illinois University, the University of Illinois Urbana-Champaign and the Northeast Illinois Council of Boy Scouts of America. In addition, he is Chairman of the Supervisory Boards, Abbott Management GmbH and Abbott Holding GmbH. He earned a Bachelor's degree in Biology and a Master's degree in Microbiology from Northern Illinois University and a Master's degree in Business Administration from the Lake Forest Graduate School of Management.
Chen, Thomas Thomas F. Chen serves as Senior Vice President - International Nutrition of Abbott Laboratories since 2008. He was appointed as Senior Vice President, Nutrition International Operations in April 2006. Previously he served as Vice President, Asia and Latin America, Abbott Nutrition International. He joined Abbott in 1988 as General Manager for Abbott Taiwan in the company's international pharmaceutical division. He has held several management positions in Asia, including regional director, greater China. Mr. Chen also served as Vice President, Pacific, Asia and Africa operations for Abbott International. Before joining Abbott, Mr. Chen held several senior management positions at Cyanamid. Mr. Chen serves on the board of the Abbott Chinese Cultural Network. He also serves on the United Way of Lake County "Success by Six" committee, an initiative to promote early education for children. He earned a Bachelor's degree in International Business from National Cheng-Chi University in Taiwan and a Master's degree in Business Administration from Indiana University.
Hance, Robert Robert B. Hance serves as Senior Vice President - Vascular of Abbott Laboratories since 2008. Mr. Hance previously served as Senior Vice President, Abbott Diabetes Care. Mr. Hance joined Abbott in 1989 as a Diagnostic Systems Specialist. He held several management positions in Abbott's Diagnostics division, including Vice President for Europe, Africa and the Middle East. Mr. Hance also served as Vice President, Vascular Solutions, Abbott Vascular before moving to Abbott Diabetes Care in 2006. Prior to joining Abbott, Mr. Hance was an associate fellow at Harvard Business School and a product development engineer at Procter & Gamble. He earned a Bachelor's degree in Chemical Engineering from the Massachusetts Institute of Technology and a Master's degree in Business Administration from Harvard Business School.
Mason, Heather Heather L. Mason serves as Senior Vice President - Diabetes Care of Abbott Laboratories. She was appointed to her current role in May 2008. Ms. Mason previously served as Vice President, Latin American Operations in Abbott's international pharmaceutical business. Ms. Mason joined Abbott in 1990. She held a number of positions in Abbott's U.S. pharmaceutical business, including oversight of Abbott's specialty pharmaceuticals, the diabetes/metabolics and oncology franchises, and managed health care. Ms. Mason also served as Vice President, International Marketing in Abbott's international pharmaceutical business. Prior to joining Abbott, Ms. Mason worked for Quaker Oats and FMC Corporation. Ms. Mason is an advisory board member of the Healthcare Businesswomen’s Association and Corporate Advisor for the Juvenile Diabetes Research Foundation and American Diabetes Association. She earned a Bachelor's degree in Engineering from the University of Michigan and a Master's degree in Business Administration from the University of Chicago.
Patton, Donald Donald V. Patton Jr. serves as Senior Vice President, U.S. Nutrition, of Abbott Laboratories where he oversees Abbott’s domestic nutrition business. He was appointed to his current role in April 2007. Previously, he served as Vice President, Diagnostic Global Commercial Operations, Abbott Diagnostics Division. Mr. Patton has held several management positions, including President and General Manager, Abbott Canada and Vice President, International Marketing, in Abbott's international pharmaceutical business. Mr. Patton also served at TAP Pharmaceuticals, a joint venture between Abbott and Takeda Chemical Industries of Japan, for 10 years. Mr. Patton began his career in teaching and prior to joining Abbott held various sales positions with Johnson & Johnson Ortho Pharmaceutical group and Becton-Dickinson. Mr. Patton also spent time as a newspaper editor and at an advertising agency. Mr. Patton serves on the Board of Governors of Smile Train, a nonprofit that provides cleft surgery for poor children around the world. He is a past President of the Biomedical Marketing Association and a member of the Adjunct Faculty for Lake Forest Graduate School of Management in Chicago. He earned a Bachelor's degree in Education from the University of Missouri at Columbia and a Master's degree in Management from Northwestern University.
Szela, Mary Mary T. Szela serves as Senior Vice President, U.S. Pharmaceuticals of Abbott Laboratories since 2008. Ms. Szela was Senior Vice President, Pharmaceutical Operations, and was appointed to this position in August 2007. Previously, she served as Vice President, Commercial Pharmaceutical Operations, where she was responsible for sales and marketing of many of Abbott's pharmaceutical brands, including HUMIRA. Ms. Szela joined Abbott in 1987 and has held several leadership positions at Abbott, including Vice President, Primary Care Commercial Operations; and Vice President of Hospital Business sector, responsible for anesthesia, acute care cardiovascular and pain management pharmaceuticals in Abbott's Hospital Products business (now Hospira). Prior to joining Abbott, Ms. Szela worked for the University of Illinois Hospital. Ms. Szela earned a Bachelor's degree in Nursing and a Master's degree in Business Administration from the University of Illinois.
Warmuth, Michael Michael J. Warmuth serves as Senior Vice President - Diagnostics of Abbott Laboratories, heading global operations for Abbott’s core laboratory diagnostics business. Previously, he was Vice President and General Manager, Hematology in Abbott's diagnostics business. He was appointed to his current role in December 2008. Mr. Warmuth joined Abbott in 1986 as part of Abbott's manufacturing professional development program. He served in a variety of management roles in manufacturing, including Divisional Vice President of pharmaceutical operations, Divisional Vice President of corporate quality operations and Vice President, Global Engineering Services. He earned a Bachelor's degree in Business Administration from the University of Wisconsin-Whitewater and a Master's degree in Business Administration from Northwestern University.
Mazzo, James
Linder, Greg Greg W. Linder serves as Vice President, Controller of Abbott Laboratories since 2001. He has been elected Corporate Officer since 1999.
Fuller, H. Laurance H. Laurance Fuller serves a Director of Abbott Laboratories. Mr. Fuller was elected president of Amoco Corporation in 1983 and chairman and chief executive officer in 1991. As the result of the merger of British Petroleum, p.l.c. and Amoco effective December 31, 1998, he became co-chairman of BP Amoco, p.l.c. He retired from that position in April 2000. He is a director of Cabot MicroElectronics Corporation and The Nature Conservancy of South Carolina, and a life trustee of The Orchestral Association and presidential counselor of Cornell University. He is Retired Co-Chairman of the Board, BP Amoco, p.l.c., London, United Kingdom (Integrated Petroleum and Chemicals Company.)
Owen, David David Owen serves as Director of Abbott Laboratories. David Owen is a British subject. He was a neurologist and Research Fellow on the Medical Unit of St. Thomas' Hospital, London, from 1962 through 1968 and a member of Parliament for Plymouth in the House of Commons from 1966 until he retired in May of 1992. In 1992, he was created a Life Peer and a Member of the House of Lords. In August of 1992, the European Union appointed him Co-Chairman of the International Conference on Former Yugoslavia. He stepped down in June of 1995. He was chairman of Global Natural Energy p.l.c. (an owner and operator of gasoline retailing sites) from 1995 to 2006. Lord Owen was Secretary for Foreign and Commonwealth Affairs from 1977 to 1979 and Minister of Health from 1974 to 1976. He is Chairman of Europe Steel, Ltd., London, United Kingdom (International Trader in Steel Products.)
Reynolds, W. Ann W. Ann Reynolds is Director of Abbott Laboratories. Dr. Reynolds served as the president of The University of Alabama at Birmingham from 1997 to 2002 and as director of its Center for Community Outreach and Development from 2002 through 2003. From 1990 to 1997, Dr. Reynolds served as chancellor of The City University of New York. Prior to that, she served as chancellor of The California State University system, provost of The Ohio State University and associate vice chancellor for research and dean of the graduate college of the University of Illinois Medical Center, Chicago. She also held appointments as professor of anatomy, research professor of obstetrics and gynecology, and acting associate dean for academic affairs at the University of Illinois College of Medicine. Dr. Reynolds is a graduate of Emporia State University (Kansas) and holds M.S. and Ph.D. degrees in zoology from the University of Iowa. She is also a director of Humana Inc., Owens-Corning, Life Technologies Corporation, and the News-Gazette, Champaign, Illinois. She is Former President, The University of Alabama at Birmingham, Birmingham, Alabama.
Roberts, Roy Roy S. Roberts serves as Director of Abbott Laboratories. Mr. Roberts has served as managing director of Reliant Equity Investors since September 2000. Mr. Roberts retired from General Motors in April 2000. At the time of his retirement, he was group vice president for North American Vehicle Sales, Service and Marketing of General Motors Corporation, having been elected to that position in October 1998. Prior to that time, he was vice president and general manager in charge of Field Sales, Service and Parts for the Vehicle Sales, Service and Marketing Group from August 1998 to October 1998, general manager of the Pontiac-GMC Division from February 1996 to October 1998, and general manager of the GMC Truck Division from October 1992 to February 1996. Mr. Roberts first joined General Motors Corporation in 1977 and became a corporate officer of General Motors Corporation in April 1987. Mr. Roberts earned a bachelor's degree from Western Michigan University. He also completed the Executive Development Program at Harvard Business School. He serves as a director of Burlington Northern Santa Fe Corporation, as Trustee Emeritus at Western Michigan University, and as past president and on the National Board of Directors for the Boy Scouts of America.
Smithburg, William William D. Smithburg serves as Director of Abbott Laboratories. Mr. Smithburg retired from Quaker Oats in October 1997. Mr. Smithburg joined Quaker Oats in 1966 and became president and chief executive officer in 1981, and chairman and chief executive officer in 1983 and also served as president from November 1990 to January 1993 and again from November 1995. Mr. Smithburg was elected to the Quaker board in 1978 and served on its executive committee until he retired. He is a director of Smurfit-Stone Container Corporation, Northern Trust Corporation, and Corning Incorporated. He is a member of the board of trustees of Northwestern University. Mr. Smithburg earned a B.S. degree from DePaul University and an M.B.A. degree from Northwestern University.
Austin, Roxanne Roxanne S. Austin serves a Director of Abbott Laboratories. She served as president and chief operating officer of DIRECTV, Inc. from June 2001 to December 2003. She also served as executive vice president of Hughes Electronics Corporation and as a member of its executive committee until December 2003. From 1997 to June 2001, Mrs. Austin was the corporate senior vice president and chief financial officer of Hughes Electronics Corporation. Mrs. Austin served as Hughes Electronics' vice president, treasurer, chief accounting officer and controller from December 1996 to July 1997; as its vice president, treasurer, and controller from July 1996 to December 1996; and as its vice president and controller from July 1993 to July 1996. Prior to joining Hughes, Mrs. Austin was a partner at the accounting firm Deloitte & Touche. Mrs. Austin earned her B.B.A. degree in accounting from the University of Texas at San Antonio. She serves on the board of trustees of the California Science Center. Mrs. Austin serves on the board of directors of Target Corporation and Teledyne Technologies Inc. She is President, Austin Investment Advisors, Newport Coast, California (Private Investment and Consulting Firm).
Daley, William William M. Daley serves a Director of Abbott Laboratories. Mr. Daley has served as the senior executive of the Midwest region and serves on the JPMorgan Chase & Co. Executive Committee and on its International Council since May 2004. He served as president, SBC Communications, Inc. (diversified telecommunications) from December 2001 to May 2004. Mr. Daley was vice chairman of Evercore Capital Partners L.P. from January to November 2001. From June to December 2000, Mr. Daley served as chairman of Vice President Albert Gore's 2000 presidential election campaign. Mr. Daley served as the U.S. Secretary of Commerce from January 1997 to June 2000. Mr. Daley serves on the board of directors of The Boeing Company, The Art Institute of Chicago, Joffrey Ballet of Chicago, Loyola University of Chicago, Northwestern Memorial Hospital, and Northwestern University. He also sits on the Council on Foreign Relations. Mr. Daley is a graduate of Loyola University in Chicago and of John Marshall Law School. He is Head of the Office of Corporate Social Responsibility and Chairman of the Midwest, JPMorgan Chase & Co., Chicago, Illinois (Banking and Financial Services Company.)
Farrell, W. James W. James Farrell serves a Director of Abbott Laboratories. Mr. Farrell served as the chairman of Illinois Tool Works Inc. from 1996 to 2006 and as its chief executive officer from 1995 to 2005. He serves on the board of directors of Allstate Insurance Company, UAL Corporation, and 3M. He is Retired Chairman and Chief Executive Officer of Illinois Tool Works Inc., Glenview, Illinois (Worldwide Manufacturer of Highly Engineered Products and Specialty Systems.)
Osborn, William William A. Osborn is Director of Abbott Laboratories. Mr. Osborn has been chairman of Northern Trust Corporation since 1995 and served as its chief executive officer from 1995 through 2007. Mr. Osborn is a director of Caterpillar Inc. and Tribune Company. He is a member of the Board of Trustees of the Museum of Science and Industry, Northwestern University, and Northwestern Memorial HealthCare and serves as chairman of the Chicago Symphony Orchestra Association. He holds a B.A. degree and an M.B.A. degree from Northwestern University. He is Chairman and former Chief Executive Officer of Northern Trust Corporation (a multibank holding company) and The Northern Trust Company, Chicago, Illinois (Banking Services Company.)
Scott, Samuel Samuel C. Scott III serves as Director of Abbott Laboratories since 2007. Mr. Scott has served as chairman, president and chief executive officer of Corn Products International since 1997. He was president of the Corn Refining Division of CPC International from 1995 through 1997, when CPC International spun off Corn Products International as a separate corporation. Mr. Scott serves on the board of directors of Bank of New York, Motorola, Inc., Accion International, the Chicago Council on Foreign Relations and Chicago Urban League. He also serves as a trustee of The Conference Board. Mr. Scott graduated from Fairleigh Dickinson University.
Tilton, Glenn Glenn F. Tilton serves as Director of Abbott Laboratories. Mr. Tilton has been chairman, president and chief executive officer of UAL Corporation and United Air Lines, Inc., a wholly owned subsidiary of UAL Corporation since September 2002. From October 2001 to August 2002, he served as vice chairman of Chevron Texaco Corporation (global energy). In addition, from May 2002 to September 2002 he served as non-executive chairman of Dynegy, Inc. (energy). From February to October 2001 he served as chairman and chief executive officer of Texaco Inc. (global energy). He currently serves as the chairman of the board of directors of the Air Transport Association, and is a member of the U.S. Travel and Tourism Advisory Board. He also serves on the board of the directors of Northwestern Memorial Hospital and on the board of trustees for the Field Museum and the Museum of Science and Industry.
Alpern, Robert Robert J. Alpern is Director of Abbott Laboratories. Dr. Robert Alpern has served as the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine since June 2004. From July 1998 to June 2004, Dr. Alpern was the Dean of The University of Texas Southwestern Medical Center. He joined the faculty of The University of Texas Southwestern Medical Center in 1987 as Associate Professor and Chief of the Division of Nephrology. Dr. Alpern also served as Professor of Internal Medicine and held the Ruth W. and Milton P. Levy, Sr. Chair in Molecular Nephrology and the Atticus James Gill, M.D. Chair in Medical Science, while on the faculty of The University of Texas Southwestern Medical Center. Dr. Alpern served on the Scientific Advisory Board of Ilypsa from 2004 until 2007 and since 2007 has served on the Scientific Advisory Board of Relypsa. Dr. Alpern also serves as a Director on the Board of Yale – New Haven Hospital. He is Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine, New Haven, Connecticut.

Insider Trading

Name Shares Traded Price
FULLER H LAURANCE 100 $54.42
FULLER H LAURANCE 1,578 $54.40
FULLER H LAURANCE 100 $54.40
FULLER H LAURANCE 5,678 $35.92
FULLER H LAURANCE 3,500 $54.40
FULLER H LAURANCE 200 $54.40
FULLER H LAURANCE 200 $54.41
MICHAEL EDWARD L 7,890 $54.54
LIEPMANN HOLGER A 7,530 $53.40
HANCE ROBERT B 1,275 $54.53
LIEPMANN HOLGER A 30 $54.76
LIEPMANN HOLGER A 7,500 $54.75
WARMUTH MICHAEL J 1,849 $54.05
WARMUTH MICHAEL J 1,849 $54.50
SMITHBURG WILLIAM D 6,177 $42.73
SMITHBURG WILLIAM D 4,880 $54.09
SMITHBURG WILLIAM D 5,100 $53.98
SMITHBURG WILLIAM D 5,678 $35.92
SMITHBURG WILLIAM D 578 $53.98
WHITE MILES D 41,579 $47.10
WHITE MILES D 2,300 $54.17
LINDER GREG W 6,500 $54.13
HANCE ROBERT B 42,561 $41.03
WHITE MILES D 36,400 $54.22
WHITE MILES D 1,100 $54.26
» Full list on Insider Trading
view people for: